Ignite Creation Date:
2024-05-06 @ 7:37 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02561871
Status:
COMPLETED
Last Update Posted:
2016-11-01
First Post:
2015-08-21
Brief Title:
A Study to Evaluate the Safety Tolerability and Immunogenicity of Ad26RSVFA2 Followed by Ad35RSVFA2 in Healthy Adult Volunteers
Sponsor:
Organization:
Crucell Holland BV
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
34
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: